Universal Ibogaine Inc
XTSX:IBO

Watchlist Manager
Universal Ibogaine Inc Logo
Universal Ibogaine Inc
XTSX:IBO
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: 1.6m CAD

Operating Margin
Universal Ibogaine Inc

-66.7%
Current
-70%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-66.7%
=
Operating Profit
-1.4m
/
Revenue
2.1m

Operating Margin Across Competitors

No Stocks Found

Universal Ibogaine Inc
Glance View

Market Cap
1.5m CAD
Industry
N/A

Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is focused on developing medicines and building a network of holistic recovery clinics for the treatment of addictions. The company treats addictions primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. Its focuses on developing ibogaine for the treatment of opioid use disorders. Ibogaine is a neuroactive compound, which is derived from various plants. Ibogaine helps to repair damaged brain tissues of the patients and helps them to recover and rebuild their lives.

IBO Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-66.7%
=
Operating Profit
-1.4m
/
Revenue
2.1m
What is the Operating Margin of Universal Ibogaine Inc?

Based on Universal Ibogaine Inc's most recent financial statements, the company has Operating Margin of -66.7%.

Back to Top